HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2015 | 548 | 612 | 89.5% | |
| HF004 | 2016 | 632 | 701 | 90.2% | |
| HF004 | 2017 | 697 | 763 | 91.3% | |
| HF004 | 2018 | 788 | 880 | 89.5% | |
| HF004 | 2019 | 983 | 1093 | 89.9% | |
| HF004 | 2020 | 1127 | 1244 | 90.6% | |
| HF004 | 2021 | 1208 | 1341 | 90.1% |
